Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details)

v3.22.2.2
Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Equity [Abstract]    
Options Outstanding, Beginning balance 5,797,185  
Options Outstanding, Granted 173,726  
Options Outstanding, Exercised (26,500)  
Options Outstanding, Cancelled/forfeited (16,888)  
Options Outstanding, Ending balance 5,927,523 5,797,185
Options Outstanding, Options exercisable 5,223,220  
Weighted Average Exercise Price, Beginning balance $ 2.22  
Weighted Average Exercise Price, Granted 9.00  
Weighted Average Exercise Price, Exercised 1.80  
Weighted Average Exercise Price, Cancelled/forfeited 1.82  
Weighted Average Exercise Price, Ending balance 2.43 $ 2.22
Weighted Average Exercise Price, Options exercisable $ 2.10  
Weighted Average Remaining Contractual Term in Years 8 years 1 month 24 days 8 years 7 months 2 days
Weighted Average Remaining Contractual Term in Years, Options exercisable 8 years 14 days  
Aggregate Intrinsic Value $ 17,273,195  
Aggregate Intrinsic Value, Options exercisable $ 16,011,367